Overview

All Sanguine study protocols and their resulting samples, which include all Sanguine at-home and apheresis collection programs, are conducted under an Institutional Review Board (IRB). Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.

Sanguine’s human serum is isolated with precision to ensure high purity and reliability for research and therapeutic applications. Collected from whole blood, our serum is carefully isolated and cryopreserved within one day to preserve the integrity of essential biomarkers. Serum include verified diagnosis for disease state, and donor-reported allergies and infectious disease history.

Well-characterized serum for cystic fibrosis research supports studies on genetic mutations, lung function, and therapeutic development to improve treatments for this inherited disorder.